| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors. | Clin Cancer Res | 2007 | 2.16 |
| 2 | Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. | Clin Cancer Res | 2008 | 1.98 |
| 3 | Pancreatic safety of incretin-based drugs--FDA and EMA assessment. | N Engl J Med | 2014 | 1.95 |
| 4 | Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years. | Med Oncol | 2007 | 0.90 |
| 5 | The European Medicines Agency review of pixantrone for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin's B-cell lymphomas: summary of the scientific assessment of the committee for medicinal products for human use. | Oncologist | 2013 | 0.80 |